At present, polymerise chain reaction (PCR) and antibody testing are the dominant ways that global healthcare systems are testing citizens for Covid-19. Both techniques have their caveats, and as the crisis unfolds researchers are looking into alternative ways to screen for the deadly disease. Chloe Kent looks into the science behind PCR and serology, and what alternatives are starting to present themselves.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
